Non Hodgkin Lymphoma (NHL) Global Market Report 2024

Non Hodgkin Lymphoma (NHL) Global Market Report 2024

Including: 1) By Type: B-Cell Lymphoma; T-Cell Lymphoma2) By Treatment: Surgery; Stem Cell Transplant; Chemotherapy; Immunotherapy; Targeted Therapy; Radiation Therapy3) By Route of Administration: Oral; Parenteral of Administration4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy5) By End-Users: Hospitals; Homecare; Specialty CentersCovering: Bayer AG; Teva Pharmaceutical Industries Ltd.; F. Hoffmann La Roche Ltd.; Merck & Co. Inc.; Eli Lilly and Co.


Non Hodgkin Lymphoma (NHL) Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non Hodgkin lymphoma (nhl) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for non Hodgkin lymphoma (nhl)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The non Hodgkin lymphoma (nhl) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:1) By Type: B-Cell Lymphoma; T-Cell Lymphoma

2) By Treatment: Surgery; Stem Cell Transplant; Chemotherapy; Immunotherapy; Targeted Therapy; Radiation Therapy

3) By Route of Administration: Oral; Parenteral; Other Routes of Administration

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels

5) By End-Users: Hospitals; Homecare; Specialty Centers; Other End Users

Companies Mentioned: Bayer AG; Teva Pharmaceutical Industries Ltd.; F. Hoffmann La Roche Ltd.; Merck & Co. Inc.; Eli Lilly and Co.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Non Hodgkin Lymphoma (NHL) Market Characteristics
3. Non Hodgkin Lymphoma (NHL) Market Trends And Strategies
4. Non Hodgkin Lymphoma (NHL) Market - Macro Economic Scenario
4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market
5. Global Non Hodgkin Lymphoma (NHL) Market Size and Growth
5.1. Global Non Hodgkin Lymphoma (NHL) Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Non Hodgkin Lymphoma (NHL) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Non Hodgkin Lymphoma (NHL) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Non Hodgkin Lymphoma (NHL) Market Segmentation
6.1. Global Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
B-Cell Lymphoma
T-Cell Lymphoma
6.2. Global Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Surgery
Stem Cell Transplant
Chemotherapy
Immunotherapy
Targeted Therapy
Radiation Therapy
6.3. Global Non Hodgkin Lymphoma (NHL) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Parenteral
Other Routes of Administration
6.4. Global Non Hodgkin Lymphoma (NHL) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Other Distribution Channels
6.5. Global Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Homecare
Specialty Centers
Other End Users
7. Non Hodgkin Lymphoma (NHL) Market Regional And Country Analysis
7.1. Global Non Hodgkin Lymphoma (NHL) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Non Hodgkin Lymphoma (NHL) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Non Hodgkin Lymphoma (NHL) Market
8.1. Asia-Pacific Non Hodgkin Lymphoma (NHL) Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Non Hodgkin Lymphoma (NHL) Market
9.1. China Non Hodgkin Lymphoma (NHL) Market Overview
9.2. China Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Non Hodgkin Lymphoma (NHL) Market
10.1. India Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Non Hodgkin Lymphoma (NHL) Market
11.1. Japan Non Hodgkin Lymphoma (NHL) Market Overview
11.2. Japan Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Non Hodgkin Lymphoma (NHL) Market
12.1. Australia Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Non Hodgkin Lymphoma (NHL) Market
13.1. Indonesia Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Non Hodgkin Lymphoma (NHL) Market
14.1. South Korea Non Hodgkin Lymphoma (NHL) Market Overview
14.2. South Korea Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Non Hodgkin Lymphoma (NHL) Market
15.1. Western Europe Non Hodgkin Lymphoma (NHL) Market Overview
15.2. Western Europe Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Non Hodgkin Lymphoma (NHL) Market
16.1. UK Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Non Hodgkin Lymphoma (NHL) Market
17.1. Germany Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Non Hodgkin Lymphoma (NHL) Market
18.1. France Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Non Hodgkin Lymphoma (NHL) Market
19.1. Italy Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Non Hodgkin Lymphoma (NHL) Market
20.1. Spain Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Non Hodgkin Lymphoma (NHL) Market
21.1. Eastern Europe Non Hodgkin Lymphoma (NHL) Market Overview
21.2. Eastern Europe Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Non Hodgkin Lymphoma (NHL) Market
22.1. Russia Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Non Hodgkin Lymphoma (NHL) Market
23.1. North America Non Hodgkin Lymphoma (NHL) Market Overview
23.2. North America Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Non Hodgkin Lymphoma (NHL) Market
24.1. USA Non Hodgkin Lymphoma (NHL) Market Overview
24.2. USA Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Non Hodgkin Lymphoma (NHL) Market
25.1. Canada Non Hodgkin Lymphoma (NHL) Market Overview
25.2. Canada Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Non Hodgkin Lymphoma (NHL) Market
26.1. South America Non Hodgkin Lymphoma (NHL) Market Overview
26.2. South America Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Non Hodgkin Lymphoma (NHL) Market
27.1. Brazil Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Non Hodgkin Lymphoma (NHL) Market
28.1. Middle East Non Hodgkin Lymphoma (NHL) Market Overview
28.2. Middle East Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Non Hodgkin Lymphoma (NHL) Market
29.1. Africa Non Hodgkin Lymphoma (NHL) Market Overview
29.2. Africa Non Hodgkin Lymphoma (NHL) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Non Hodgkin Lymphoma (NHL) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Non Hodgkin Lymphoma (NHL) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Non Hodgkin Lymphoma (NHL) Market Competitive Landscape And Company Profiles
30.1. Non Hodgkin Lymphoma (NHL) Market Competitive Landscape
30.2. Non Hodgkin Lymphoma (NHL) Market Company Profiles
30.2.1. Bayer AG
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Teva Pharmaceutical Industries Ltd.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. F. Hoffmann La Roche Ltd.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Merck & Co. Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Eli Lilly and Co.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Global Non Hodgkin Lymphoma (NHL) Market Competitive Benchmarking
32. Global Non Hodgkin Lymphoma (NHL) Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Non Hodgkin Lymphoma (NHL) Market
34. Non Hodgkin Lymphoma (NHL) Market Future Outlook and Potential Analysis
34.1 Non Hodgkin Lymphoma (NHL) Market In 2028 - Countries Offering Most New Opportunities
34.2 Non Hodgkin Lymphoma (NHL) Market In 2028 - Segments Offering Most New Opportunities
34.3 Non Hodgkin Lymphoma (NHL) Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies
35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings